Structure–activity studies on diphenylpyrazine derivatives: A novel class of prostacyclin receptor agonists
Authors:
- Tetsuo AsakiTATetsuo Asaki
- Taisuke HamamotoTHTaisuke Hamamoto
- Yukiteru SugiyamaYSYukiteru Sugiyama
- Keiichi KuwanoKKKeiichi Kuwano
- Kenji KuwabaraKKKenji Kuwabara
- 1 November 2007
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (21) , 6692-6704
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Discovery of diphenylcarbamate derivatives as highly potent and selective IP receptor agonists: Orally active prostacyclin mimetics. Part 3Bioorganic & Medicinal Chemistry Letters, 2005
- A simple stereoselective synthesis and biological evaluation of FR181157: orally active prostacyclin mimeticBioorganic & Medicinal Chemistry Letters, 2003
- Molecular design of novel PGI2 agonists without PG skeleton. IVBioorganic & Medicinal Chemistry Letters, 1995
- Pharmacokinetics and Platelet Antiaggregating Effects of Beraprost, an Oral Stable Prostacyclin Analogue, in Healthy VolunteersJournal of Cardiovascular Pharmacology, 1993
- Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acidJournal of Medicinal Chemistry, 1993
- Prostanoid receptors and their biological actionsProgress in Lipid Research, 1993
- Nonprostanoid prostacyclin mimetics. 3. Structural variations of the diphenyl heterocycle moietyJournal of Medicinal Chemistry, 1992
- Nonprostanoid prostacyclin mimetics. 2. 4,5-diphenyloxazole derivatives.Journal of Medicinal Chemistry, 1992
- Beraprost SodiumCardiovascular Drug Reviews, 1988
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976